• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The State Struggle: Paying for Excessively Priced Drugs

Article

High-priced treatments continue to crush state budgets. With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country.

High-priced treatments continue to crush state budgets. California, for example, has set aside $300 million to pay for new hepatitis C drugs. But unfortunately, that cost is just the tip of the iceberg, according to an article from The Fresno Bee.

With more drugs carrying 6-figure price tags, a problematic situation is playing out across the country. There’s the “impossible math” around how to afford hepatitis treatment in Rhode Island, as Rhode Island Public Radio reported. The state’s prison healthcare budget of $19 million must somehow pay for a hep C drug that will cost $150,000 for a round of treatment.

Read more at AHIP Coverage: http://bit.ly/1AUSgi9

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.